PRICE T ROWE ASSOCIATES INC /MD/
Position in TVTX — Travere Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,910,574
+$62,883,819 QoQ
Shares Held
1,318,616
+225.7% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 315 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. TVTX ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in TVTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,910,574 | 1,318,616 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,026,755 | 404,805 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,086,988 | 394,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,898,711 | 79,444 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,056,305 | 71,372 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $955,297 | 53,309 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $689,901 | 39,604 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,936,071 | 281,349 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $274,885 | 33,441 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $239,079 | 31,009 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $252,268 | 28,061 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $239,878 | 26,832 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $570,639 | 37,151 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $703,712 | 31,290 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $609,827 | 28,998 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $763,199 | 30,974 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $651,011 | 26,868 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $424,844 | 16,486 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $440,674 | 14,197 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||